1-3 of 3
Seth Ettenberg, PhD
Close
Sort by
Journal Articles

ACTR087, Autologous T Lymphocytes Expressing Antibody Coupled T-Cell Receptors (ACTR), Induces Complete Responses in Patients with Relapsed or Refractory CD20-Positive B-Cell Lymphoma, in Combination with Rituximab

Luke Paul Akard, MD, Samantha Jaglowski, MD, Steven M. Devine, MD, Matthew S. McKinney, MD, Michael Vasconcelles, MD, Heather Huet, PhD, Seth Ettenberg, PhD, Ann Ranger, PhD, Jeremy S. Abramson, MD MMSc
Journal: Blood
Blood (2017)
https://doi.org/10.1182/blood.V130.Suppl_1.580.580
Published: 2017
Journal Articles

Adaptability of Antibody-Coupled T Cell Receptor (ACTR) Engineered Autologous T Cells in Combination with Daratumumab over CAR-Based Approaches

Taylor Hickman, BS, Adrianna Graziano, Katie O'Callaghan, PhD, Ryan Boomer, BA, Eugene Choi, MS, Allison Nelson, BS, Greg Motz, PhD, Jessica Sachs, MD, Birgit Schultes, PhD, Seth Ettenberg, PhD, Tooba Cheema, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3189.
https://doi.org/10.1182/blood.V130.Suppl_1.3189.3189
Published: 2017
Journal Articles

Anti-DKK1 mAb (BHQ880) as a Potential Therapeutic for Multiple Myeloma.

Mariateresa Fulciniti, PhD, Pierfrancesco Tassone, MD, Teru Hideshima, MD, Sonia Vallet, MD, Seth Ettenberg, PhD, David Stover, PhD, Simona Blotta, MD, Zhenxin Shen, PhD, Maria Teresa Dimartino, PhD, Paola Neri, MD, Rao Prabhala, PhD, Raje Nopur, MD, Steven R. Goldring, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD
Journal: Blood
Blood (2007) 110 (11): 551.
https://doi.org/10.1182/blood.V110.11.551.551
Published: 2007